Alistair Stewart McLaren

Alistair Stewart McLaren

Auto-generated profile, based on publicly available information

Alistair Stewart McLaren

CRUK Scotland Institute, Glasgow, United Kingdom

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2024 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
RFRana Fetit
Rana Fetit
AMAlistair S. McLaren
Alistair S. McLaren
MWMark White
Mark White
MMMegan L. Mills
Megan L. Mills
JFJohn Falconer
John Falconer
CSColin W. Steele
Colin W. Steele
Neutrophils are a highly heterogeneous cellular population. However, a thorough examination of the different transcriptional neutrophil states between health and malignancy has not been performed. We utilized single-cell RNA sequencing of human and murine datasets, both publicly available and independently generated, to identify neutrophil transcriptomic subtypes and developmental lineages in health and malignancy. Datasets of lung, breast, and colorectal cancer were integrated to establish and validate neutrophil gene signatures. Pseudotime analysis was used to identify genes driving neutrophil development from health to cancer. Finally, ligand–receptor interactions and signaling pathways between neutrophils and other immune cell populations in primary colorectal cancer and metastatic colorectal cancer were investigated. We define two main neutrophil subtypes in primary tumors: an activated subtype sharing the transcriptomic signatures of healthy neutrophils; and a tumor-specific subtype. This signature is conserved in murine and human cancer, across different tumor types. In colorectal cancer metastases, neutrophils are more heterogeneous, exhibiting additional transcriptomic subtypes. Pseudotime analysis implicates IL1β/CXCL8/CXCR2 axis in the progression of neutrophils from health to cancer and metastasis, with effects on T-cell effector function. We propose that the emergence of metastatic-specific neutrophil subtypes is driven by the IL1β/CXCL8/CXCR2 axis, with the evolution of different transcriptomic signals that impair T-cell function at the metastatic site. Thus, a better understanding of neutrophil transcriptomic programming could optimize immunotherapeutic interventions into early and late interventions, targeting different neutrophil states. Significance: We identify two recurring neutrophil populations and demonstrate their staged evolution from health to malignancy through the IL1β/CXCL8/CXCR2 axis, allowing for immunotherapeutic neutrophil-targeting approaches to counteract immunosuppressive subtypes that emerge in metastasis.

20 November 2023 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
AMAlistair Stewart McLaren
Alistair Stewart McLaren
JSJohannes A Spoor
Johannes A Spoor
DCDouglas Cartwright
Douglas Cartwright
GNGregory Naylor
Gregory Naylor
SBStephen Barclay
Stephen Barclay
TEThomas R Jeffry Evans
Thomas R Jeffry Evans
Objective The COVID-19 pandemic had an undoubted impact on the provision of elective and emergency cancer care, including the diagnosis and management of patients with hepatocellular carcinoma (HCC). Our aim was to determine the effects of the COVID-19 pandemic on patients with HCC in the West of Scotland. Design This was a retrospective audit of a prospectively collated database of patients presented to the West of Scotland Multidisciplinary Team (MDT) between April and October 2020 (during the pandemic), comparing baseline demographics, characteristics of disease at presentation, diagnostic workup, treatment and outcomes with patients from April to October 2019 (pre pandemic). Results There was a 36.5% reduction in new cases referred to the MDT during the pandemic. Patients presented at a significantly later Barcelona Cancer Liver Clinic stage (24% stage D during the pandemic, 9.5% pre pandemic, p<0.001) and with a significantly higher Child-Pugh Score (46% Child-Pugh B/C during the pandemic vs 27% pre pandemic, p<0.001). We observed a reduction in overall survival (OS) among all patients with a median OS during the pandemic of 6 months versus 17 months pre pandemic (p=0.048). Conclusion The impact of the COVID-19 pandemic is likely to have contributed to a reduction in the presentation of new cases and survival among patients with HCC in the West of Scotland. The reason for this is likely multifactorial, but disruption of standard care is likely to have played a significant role. Resources should be provided to address the backlog and ensure there are robust investigation and management pathways going forward.


13 May 2025
Verified
Other
Open access
RFRana Fetit
Rana Fetit
AMAlistair S. McLaren
Alistair S. McLaren
MWMark White
Mark White
MMMegan L. Mills
Megan L. Mills
JFJohn Falconer
John Falconer
CSColin W. Steele
Colin W. Steele
CD4+ T cells are transcriptomically altered in metastasis. A and B, UMAP plots of CD4+ and CD8+ T cells in PT and LM grouped by cell type and tumor type, respectively. C, Differential gene expression of CD4+ T cells in LM compared with PT. D and E, GO and KEGG analyses of metastatic CD4+ T cells. F and G, Global cell-cell communication network and the interaction strengths between neutrophils, CD4+, CD8+, and Tregs. H–J, The contribution of each L-R pair to the overall signaling pathway for CXCL, IL1, and TNF pathways. K–M, Visualization of the cell-cell communication patterns mediated by each significant L-R pair for the three pathways.

29 February 2024
Verified
Other
Open access
PDF file
RFRana Fetit
Rana Fetit
AMAlistair S. McLaren
Alistair S. McLaren
MWMark White
Mark White
MMMegan L. Mills
Megan L. Mills
JFJohn Falconer
John Falconer
CSColin W. Steele
Colin W. Steele
Figure S2. Gene expression and neutrophil signatures in neutrophils from healthy and tumour tissue.